Skip to content
Madrigal Pharmaceuticals, Inc. Corporate Site
Contact Us
Search for:
MASH/NASH
Clinical Trials
Publications
Request Medical Information
Submit an Educational Grant Request
Investigator-Initiated Studies
Areas of Interest
Submit a Proposal
FAQs
Treatment with resmetirom for up to two years led to improvement in liver stiffness, fibrosis biomarkers, fibrosis scores and portal hypertension in 122 patients with compensated MASH cirrhosis
Oral Presentation
File size: 1.05 MB
Created: 13-05-2025
Updated: 13-05-2025
Hits: 58
Download
Preview
Page load link
Go to Top
